Literature DB >> 2474499

Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype.

A Rozalski1, L Brade, P Kosma, B J Appelmelk, C Krogmann, H Brade.   

Abstract

Murine monoclonal and rabbit polyclonal antibodies raised against the lipopolysaccharides (LPS) of Re mutants of Salmonella minnesota, Proteus mirabilis, and Escherichia coli were serologically characterized. Using natural Re LPS and natural and synthetic partial structures thereof, representing the 3-deoxy-D-manno-2-octulosonic acid (KDO) or lipid A region or both, the epitope specificities of four monoclonal antibodies were defined. Clones 20 (immunoglobulin M [IgM]) and 25 (IgG3) recognize a terminal alpha-pyranosidically linked KDO monosaccharide residue and the alpha-2,4-linked KDO disaccharide, respectively, as the immunodominant group. Therefore, these two antibodies are core antibodies which do not require the presence of lipid A constituents for binding. The minimal structure enabling binding of clone 17 (IgG2b) is a pseudotetrasaccharide of the sequence alpha-KDO-(2----4)-alpha-KDO-(2----6)-beta-glucosamine-(1----6)- glucosaminitol with two amide-linked 3-hydroxytetradecanoic acid residues. The smallest structure with which clone 22 (IgG3) reacted was de-O-acylated Re LPS. Therefore, clones 17 and 22 are LPS antibodies requiring both the lipid A and the KDO region for binding. Phosphoryl residues of the lipid A moiety in Re LPS are dispensable for the reaction with clone 17, whereas they are necessary for that with clone 22. These four different antibody types were also detected in polyclonal rabbit antisera and could be distinguished from each other by absorption experiments. It was found that type 20 and 25 antibodies either were not present or were present only in small amounts and that the majority of the antibodies were of types 17 and 22. From these data, we conclude that the immunodominant structures of Re LPS comprise both the KDO and lipid A domains.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474499      PMCID: PMC313507          DOI: 10.1128/iai.57.9.2645-2652.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Isolation and structural characterization of an 8-O-(4-amino-4-deoxy-beta-L-arabinopyranosyl)-3-deoxy-D-manno- octulosonic acid disaccharide in the lipopolysaccharide of a Proteus mirabilis deep rough mutant.

Authors:  Z Sidorczyk; W Kaca; H Brade; E T Rietschel; V Sinnwell; U Zähringer
Journal:  Eur J Biochem       Date:  1987-10-15

2.  Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities.

Authors:  C Galanos; O Lüderitz; E T Rietschel; O Westphal; H Brade; L Brade; M Freudenberg; U Schade; M Imoto; H Yoshimura
Journal:  Eur J Biochem       Date:  1985-04-01

Review 3.  Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Current and future aspects.

Authors:  H Brade; L Brade; E T Rietschel
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-04

Review 4.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

5.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

6.  Structural relationship of Salmonella O and R antigens.

Authors:  O Lüderitz; C Galanos; H J Risse; E Ruschmann; S Schlecht; G Schmidt; H Schulte-Holthausen; R Wheat; O Westphal; J Schlosshardt
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

7.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

8.  A new type of carbohydrate-containing synthetic antigen: synthesis of carbohydrate-containing polyacrylamide copolymers having the specificity of O:3 and O:4 factors of Salmonella.

Authors:  A B Levinsky; B A Dmitriev; N K Kochetkov
Journal:  Carbohydr Res       Date:  1984-06-01       Impact factor: 2.104

9.  The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment.

Authors:  L Brade; K Brandenburg; H M Kuhn; S Kusumoto; I Macher; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

10.  Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-octulosonate region of bacterial lipopolysaccharide.

Authors:  L Brade; P Kosma; B J Appelmelk; H Paulsen; H Brade
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

View more
  11 in total

1.  Pore formation by complement in the outer membrane of gram-negative bacteria studied with asymmetric planar lipopolysaccharide/phospholipid bilayers.

Authors:  G Schröder; K Brandenburg; L Brade; U Seydel
Journal:  J Membr Biol       Date:  1990-11       Impact factor: 1.843

2.  Loss of the waaL O-antigen ligase prevents surface activation of the flagellar gene cascade in Proteus mirabilis.

Authors:  Randy M Morgenstein; Katy M Clemmer; Philip N Rather
Journal:  J Bacteriol       Date:  2010-04-09       Impact factor: 3.490

Review 3.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

4.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.

Authors:  H M Kuhn
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

6.  Specificity of rabbit antisera against the rough lipopolysaccharide of Salmonella minnesota R4 (chemotype Rd2P-)

Authors:  A Swierzko; L Brade; H Paulsen; H Brade
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide.

Authors:  L Brade; O Holst; P Kosma; Y X Zhang; H Paulsen; R Krausse; H Brade
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart.

Authors:  Y Fu; M Baumann; P Kosma; L Brade; H Brade
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Escherichia coli K-12 Suppressor-free Mutants Lacking Early Glycosyltransferases and Late Acyltransferases: minimal lipopolysaccharide structure and induction of envelope stress response.

Authors:  Gracjana Klein; Buko Lindner; Werner Brabetz; Helmut Brade; Satish Raina
Journal:  J Biol Chem       Date:  2009-04-03       Impact factor: 5.157

10.  Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes.

Authors:  N M van der Meer; B J Appelmelk; A M Verweij-van Vught; W Nimmich; P Kosma; L G Thijs; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.